Our previous study [35] demonstrated that GRHL2 was more highly expressed in breast cancer tissues than in normal tissues, and the high expression of GRHL2 was associated with a worse prognosis for breast cancer patients. This evidence concerns the gene GRHL2 and breast cancer.